{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:38:45Z","timestamp":1777099125702,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"H.Y.; National Clinical Key Specialty Project - Next-generation Integrated Pathological Diagnosis of Oncologic Diseases under the Department of Pathology","award":["YWP2023-001;"],"award-info":[{"award-number":["YWP2023-001;"]}]},{"name":"Shanghai Clinical Specialty Construction Project","award":["shslczdzk01302;"],"award-info":[{"award-number":["shslczdzk01302;"]}]},{"name":"Shanghai Science and Technology Innovation Action Plan - Natural Science Foundation Project","award":["23ZR1410000;"],"award-info":[{"award-number":["23ZR1410000;"]}]},{"name":"Shanghai Science and Technology Innovation Action Plan - Natural Science Foundation Project","award":["23ZR1410200;"],"award-info":[{"award-number":["23ZR1410200;"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Carboxypeptidase Z (CPZ) is a newly identified member of the metallopeptidase family, primarily reported in rats; however, its distribution in normal human tissues and expression characteristics in tumor tissues remain unclear. This study uses high-throughput and mass production technology for tissue microarray (TMA) to perform immunohistochemical staining of CPZ, for the first time delineating its distribution and expression in normal tissues and various tumors throughout the body, to discuss its potential pathologic value. CPZ exhibited varying degrees of cytoplasmic positive expression in the normal hepatocytes, pancreatic islets, and gallbladder epithelium, with no expression observed in other normal tissues. The positive expression rates of CPZ in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), metastatic liver tumors, and normal liver tissue were 90.8% (109\/120), 27.7% (13\/47), 0% (0\/22), and 100% (81\/81), respectively. The sensitivity and specificity for diagnosing HCC with any of the 3 markers (CPZ, arginase-1 (Arg-1), and hepatocyte paraffin antigen-1 (Hep Par-1)) positive were 96.7% (116\/120) and 65.2% (45\/69), respectively. The sensitivity and specificity for diagnosing HCC with all 3 markers positive were 70.8% (85\/120) and 100% (69\/69), respectively. The sensitivity and specificity for diagnosing HCC with both CPZ and Arg-1 positive were 79.2% (95\/120) and 95.7% (66\/69), respectively. The sensitivity and specificity for diagnosing HCC with both CPZ and Hep Par-1 positive were 76.7% (92\/120) and 97.1% (67\/69), respectively. The sensitivity and specificity for diagnosing HCC with both Arg-1 and Hep Par-1 positive were 72.5% (87\/120) and 98.6% (68\/69), respectively. The ROC curve indicated that the combined detection of CPZ, Arg-1, and Hep Par-1 had the best diagnostic value for HCC (AUC=0.939, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). However, for individual detection, CPZ had the highest AUC value among the 3 markers (AUC=0.908, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). CPZ was not observed to be positive in the majority of 897 cases of solid tumors. Utilizing the TMA repository, we propose for the first time that CPZ may serve as a useful adjunctive tool for the diagnosis or differential diagnosis of HCC in routine surgical pathology practice. CPZ shows a trend of superiority over Arg-1 and Hep Par-1, particularly in poorly differentiated HCC.<\/jats:p>","DOI":"10.1097\/pas.0000000000002393","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T07:00:20Z","timestamp":1744009220000},"page":"711-729","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["CPZ"],"prefix":"10.1097","volume":"49","author":[{"given":"Minying","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongkui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieakesu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47","author":"Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1074\/jbc.272.16.10543","article-title":"Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase","volume":"272","author":"Song","year":"1997","journal-title":"J Biol Chem"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/dna.1998.17.311","article-title":"Cloning, sequence analysis, and distribution of rat metallocarboxypeptidase Z","volume":"17","author":"Xin","year":"1998","journal-title":"DNA Cell Biol"},{"key":"R6-20250618","first-page":"1050","article-title":"Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors","volume":"143","author":"Wennerberg","year":"1993","journal-title":"Am J Pathol"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/labinvest.3700699","article-title":"The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1","volume":"88","author":"Butler","year":"2008","journal-title":"Lab Invest"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.9043","article-title":"Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver","volume":"93","author":"Zimmerman","year":"2001","journal-title":"Cancer"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1309\/8L872RPHEJRKF5JJ","article-title":"Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma","volume":"119","author":"Kakar","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1746-1596-7-149","article-title":"The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1","volume":"7","author":"Radwan","year":"2012","journal-title":"Diagn Pathol"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.5858\/2007-131-1648-BPIDIH","article-title":"Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms","volume":"131","author":"Kakar","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/PAS.0b013e3181e5dffa","article-title":"Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms","volume":"34","author":"Yan","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R13-20250618","first-page":"398","article-title":"The applicability of a human immunohistochemical panel to mouse models of hepatocellular neoplasia","volume":"65","author":"Salleng","year":"2015","journal-title":"Comp Med"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.7314\/APJCP.2015.16.16.7031","article-title":"Modulation of L-arginine-arginase metabolic pathway enzymes: immunocytochemistry and mRNA expression in peripheral blood and tissue levels in head and neck squamous cell carcinomas in North East India","volume":"16","author":"Srivastava","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/prca.201100103","article-title":"Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients","volume":"7","author":"Ye","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3390\/diagnostics11122351","article-title":"Large-scale tissue microarray evaluation corroborates high specificity of high-level arginase-1 immunostaining for hepatocellular carcinoma","volume":"11","author":"Lennartz","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.5858\/132.11.1723","article-title":"Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions","volume":"132","author":"Wang","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"128","DOI":"10.21037\/tcr.2019.11.20","article-title":"Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma","volume":"9","author":"Wang","year":"2020","journal-title":"Transl Cancer Res"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2008.85","article-title":"Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum","volume":"21","author":"Shafizadeh","year":"2008","journal-title":"Mod Pathol"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1359\/jbmr.081014","article-title":"Carboxypeptidase Z (CPZ) links thyroid hormone and Wnt signaling pathways in growth plate chondrocytes","volume":"24","author":"Wang","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1242\/dev.00686","article-title":"Carboxypeptidase Z (CPZ) modulates Wnt signaling and regulates the development of skeletal elements in the chicken","volume":"130","author":"Moeller","year":"2003","journal-title":"Development"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0925-4773(01)00306-9","article-title":"Metallocarboxypeptidase Z is dynamically expressed in mouse development","volume":"102","author":"Novikova","year":"2001","journal-title":"Mech Dev"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/002215540104900612","article-title":"Immunohistochemical localization and comparison of carboxypeptidases D, E, and Z, alpha-MSH, ACTH, and MIB-1 between human anterior and corticotroph cell \u201cbasophil invasion\u201d of the posterior pituitary","volume":"49","author":"Fan","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1177\/002215540205001111","article-title":"Immunohistochemical localization of carboxypeptidases D, E, and Z in pituitary adenomas and normal human pituitary","volume":"50","author":"Fan","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"e1006787","DOI":"10.1371\/journal.pgen.1006787","article-title":"Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma","volume":"13","author":"McDaniel","year":"2017","journal-title":"PLoS Genet"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00000478-200208000-00002","article-title":"Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein","volume":"26","author":"Chu","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00428-005-0081-5","article-title":"Elevated hepatocyte paraffin 1 and neprilysin expression in hepatocellular carcinoma are correlated with longer survival","volume":"448","author":"Mondada","year":"2006","journal-title":"Virchows Arch"},{"key":"R29-20250618","first-page":"981","article-title":"Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases","volume":"36","author":"Atta","year":"2021","journal-title":"Histol Histopathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:00:17Z","timestamp":1750280417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002393"}},"subtitle":["A Highly Sensitive Diagnostic Biomarker for the Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma, Particularly in Poorly Differentiated Hepatocellular Carcinoma"],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002393","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}